Cargando…

Versatile Platinum(IV) Prodrugs of Naproxen and Acemetacin as Chemo-Anti-Inflammatory Agents

SIMPLE SUMMARY: Traditional intravenous platinum(II) chemotherapy drugs such as cisplatin, oxaliplatin and carboplatin are highly effective in treating multiple cancer types. Unfortunately, this treatment is most often beset with detrimental side effects that inevitably impact the patient’s willingn...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aputen, Angelico D., Elias, Maria George, Gilbert, Jayne, Sakoff, Jennette A., Gordon, Christopher P., Scott, Kieran F., Aldrich-Wright, Janice R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10177380/ https://www.ncbi.nlm.nih.gov/pubmed/37173934 http://dx.doi.org/10.3390/cancers15092460

Ejemplares similares

Potent Chlorambucil-Platinum(IV) Prodrugs
por: Aputen, Angelico D., et al.
Publicado: (2022)

Bioactive Platinum(IV) Complexes Incorporating Halogenated Phenylacetates
por: Aputen, Angelico D., et al.
Publicado: (2022)

Cyclooxygenase-Inhibiting Platinum(IV) Prodrugs with Potent Anticancer Activity
por: Khoury, Aleen, et al.
Publicado: (2022)

Potent Platinum(IV) Prodrugs That Incorporate a Biotin Moiety to Selectively Target Cancer Cells
por: Khoury, Aleen, et al.
Publicado: (2022)

Novel Planar Pt(II) Cyclometallated Cytotoxic Complexes with G-Quadruplex Stabilisation and Luminescent Properties
por: McGhie, Brondwyn S., et al.
Publicado: (2022)

Synthesis and Characterisation of Fluorescent Novel Pt(II) Cyclometallated Complexes with Anticancer Activity
por: McGhie, Brondwyn S., et al.
Publicado: (2023)

Acemetacin-induced fixed drug eruption
por: Cebeci, Filiz, et al.
Publicado: (2016)

Ligand Evolution in the Photoactivatable Platinum(IV) Anticancer Prodrugs
por: Huang, Jingjing, et al.
Publicado: (2022)

Repurposing Platinum(IV) Prodrugs to Modulate Mitochondrial Metabolism
por: Zacharioudakis, Emmanouil, et al.
Publicado: (2023)

Acemetacin cocrystal structures by powder X-ray diffraction
por: Bolla, Geetha, et al.
Publicado: (2017)

Recrystallization Mediates the Gelation of Amorphous Drugs: The Case of Acemetacin
por: Teng, Manlin, et al.
Publicado: (2023)

Cell-permeable lanthanide–platinum(iv) anti-cancer prodrugs
por: Yao, Kezi, et al.
Publicado: (2021)

Tumor-targeted dual-action NSAID-platinum(iv) anticancer prodrugs
por: Kastner, Alexander, et al.
Publicado: (2023)

A platinum–ruthenium hybrid prodrug with multi-enzymatic activities for chemo-catalytic therapy of hypoxic tumors
por: Yang, Gang-Gang, et al.
Publicado: (2022)

Induction of targeted necrosis with HER2-targeted platinum(iv) anticancer prodrugs
por: Wong, Daniel Yuan Qiang, et al.
Publicado: (2015)

A platinum(IV) prodrug strategy to overcome glutathione-based oxaliplatin resistance
por: Fronik, Philipp, et al.
Publicado: (2022)

Self-assembly nanoplatform of platinum (Ⅳ) prodrug for enhanced ovarian cancer therapy
por: Ma, Xiao, et al.
Publicado: (2023)

Glutathione boosting the cytotoxicity of a magnetic platinum(iv) nano-prodrug in tumor cells
por: Zhu, Zhenzhu, et al.
Publicado: (2016)

Sustained Release of Levobupivacaine, Lidocaine, and Acemetacin from Electrosprayed Microparticles: In Vitro and In Vivo Studies
por: Chen, Jian-Ming, et al.
Publicado: (2020)

Albumin-encapsulated Nanoparticles of Naproxen Platinum(IV) Complexes with Inflammation Inhibitory Competence Displaying Effective Antitumor Activities in vitro and in vivo
por: Li, Linming, et al.
Publicado: (2021)

Pt(IV) prodrug initiated microparticles from microfluidics for tumor chemo-, photothermal and photodynamic combination therapy
por: Zhang, Qingfei, et al.
Publicado: (2022)

Albumin-Encapsulated Nanoparticles of Naproxen Platinum(IV) Complexes with Inflammation Inhibitory Competence Displaying Effective Antitumor Activities in vitro and in vivo [Corrigendum]
Publicado: (2023)

A focused library synthesis and cytotoxicity of quinones derived from the natural product bolinaquinone
por: Ghods, Azadeh, et al.
Publicado: (2018)

Multi-Acting Mitochondria-Targeted Platinum(IV) Prodrugs of Kiteplatin with α-Lipoic Acid in the Axial Positions
por: Savino, Salvatore, et al.
Publicado: (2018)

The impact of whole human blood on the kinetic inertness of platinum(iv) prodrugs – an HPLC-ICP-MS study
por: Theiner, Sarah, et al.
Publicado: (2018)

Oxaliplatin-Based Platinum(IV) Prodrug Bearing Toll-like Receptor 7 Agonist for Enhanced Immunochemotherapy
por: Tang, Li, et al.
Publicado: (2019)

Structure–Activity Relationships of Triple-Action Platinum(IV) Prodrugs with Albumin-Binding Properties and Immunomodulating Ligands
por: Fronik, Philipp, et al.
Publicado: (2021)

pH/redox sensitive nanoparticles with platinum(iv) prodrugs and doxorubicin enhance chemotherapy in ovarian cancer
por: Zhang, Guyu, et al.
Publicado: (2019)

Investigation of eco-friendly fluorescence quenching probes for assessment of acemetacin using silver nanoparticles and acriflavine reagent
por: Ghonim, Rana, et al.
Publicado: (2023)

Layer-by-layer nanoparticles co-loading gemcitabine and platinum (IV) prodrugs for synergistic combination therapy of lung cancer
por: Zhang, Rongrong, et al.
Publicado: (2017)

Acemetacin cocrystals and salts: structure solution from powder X-ray data and form selection of the piperazine salt
por: Sanphui, Palash, et al.
Publicado: (2014)

Improving the anticancer activity of platinum(iv) prodrugs using a dual-targeting strategy with a dichloroacetate axial ligand
por: Liu, Fengfan, et al.
Publicado: (2019)

Synthesis, Characterization and Biological Investigation of the Platinum(IV) Tolfenamato Prodrug–Resolving Cisplatin-Resistance in Ovarian Carcinoma Cell Lines
por: Barth, Marie-Christin, et al.
Publicado: (2023)

Combination of IDO inhibitors and platinum(IV) prodrugs reverses low immune responses to enhance cancer chemotherapy and immunotherapy for osteosarcoma
por: Xiang, Dongquan, et al.
Publicado: (2023)

In situ oxidative polymerization of platinum(iv) prodrugs in pore-confined spaces of CaCO(3) nanoparticles for cancer chemoimmunotherapy
por: Wei, Fangmian, et al.
Publicado: (2023)

Chloromethyl Glycosides as Versatile Synthons to Prepare Glycosyloxymethyl‐Prodrugs
por: Elferink, Hidde, et al.
Publicado: (2022)

An ultrasound-activatable platinum prodrug for sono-sensitized chemotherapy
por: Liu, Gongyuan, et al.
Publicado: (2023)

Photoallergy to Naproxen
por: Rojas Perez-Ezquerra, Patricia, et al.
Publicado: (2021)

Cell membranes targeted unimolecular prodrug for programmatic photodynamic-chemo therapy
por: Yuan, Jie, et al.
Publicado: (2021)

The interactions of novel mononuclear platinum-based complexes with DNA
por: Johnson, Ben W., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_fv79qes5trqqeo2kk6vq152j3e